Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Canna-Global Acquisition A | CNGL | Jul 26, 2024 | 10.43 | 0.00 |
Canna-Global Acquisition Unit | CNGLU | Jul 26, 2024 | 10.51 | 0.00 |
Cannae | CNNE | Jul 26, 2024 | 20.15 | +1.77 |
Canoo A | GOEV | Jul 26, 2024 | 2.07 | +0.49 |
Canopy Growth | CGC | Jul 26, 2024 | 7.30 | +1.96 |
Cantaloupe | CTLP | Jul 26, 2024 | 7.81 | +2.49 |
Canterbury Park | CPHC | Jul 26, 2024 | 21.51 | +0.05 |
Capital Bancorp | CBNK | Jul 26, 2024 | 25.88 | -0.19 |
Capital City Bank Group | CCBG | Jul 26, 2024 | 35.63 | +0.03 |
Capital One Financial | COF | Jul 26, 2024 | 149.36 | +0.86 |
Capital One Financial I Pref | COF-I | Jul 26, 2024 | 19.85 | +0.46 |
Capital One Financial J Pref | COF-J | Jul 26, 2024 | 19.04 | +0.37 |
Capital One Financial K Pref | COF-K | Jul 26, 2024 | 19.17 | +0.21 |
Capital One Financial L Pref | COF-L | Jul 26, 2024 | 18.01 | +0.06 |
Capital One Financial N Pref | COF-N | Jul 26, 2024 | 17.46 | +0.52 |
Capital Product Partners | CPLP | Jul 26, 2024 | 16.35 | -2.10 |
Capital Southwest | CSWC | Jul 26, 2024 | 26.00 | +1.33 |
Capitol Federal Financial | CFFN | Jul 26, 2024 | 6.48 | +3.35 |
Capri Holdings | CPRI | Jul 26, 2024 | 33.75 | +1.32 |
Capricor Therapeutics | CAPR | Jul 26, 2024 | 4.37 | -1.35 |
Captivision | CAPT | Jul 26, 2024 | 2.22 | -3.69 |
Cara Therapeutics | CARA | Jul 26, 2024 | 0.37 | +2.00 |
Caravelle International Group | CACO | Jul 26, 2024 | 0.42 | -0.53 |
Carbon Revolution | CREV | Jul 26, 2024 | 9.05 | +46.68 |
Cardiff Oncology | CRDF | Jul 26, 2024 | 2.34 | -1.06 |
Cardinal Health | CAH | Jul 26, 2024 | 98.35 | +1.49 |
Cardio Diagnostics | CDIO | Jul 26, 2024 | 0.47 | +0.47 |
Cardiol Therapeutics | CRDL | Jul 26, 2024 | 2.25 | +0.45 |
Cardlytics | CDLX | Jul 26, 2024 | 8.83 | +5.50 |
CareCloud | CCLD | Jul 26, 2024 | 2.25 | +6.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.